Related Experiment Video

Updated: Jul 24, 2026

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

[Inhibition of the motility of melanoma cells using interference RNA against CD9]

Pablo F Peñas1, María A García-López, Olga Barreiro del Río

  • 1Servicios de Dermatología, Hospital Universitario de la Princesa, Universidad Autónoma, Diego de León 62, 28006 Madrid, Spain. pablofp@aedv.es

Actas Dermo-Sifiliograficas
|February 16, 2006
PubMed
Abstract

Insights

RNA interference effectively silenced CD9 and CD151 expression in melanoma cells. CD9 knockdown significantly inhibited cell motility, suggesting tetraspanins as potential therapeutic targets for melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Melanoma is an aggressive skin cancer, with unknown causes for its high mortality rate.
  • Current treatments for melanoma are largely unsuccessful.
  • RNA interference (iRNA) allows targeted silencing of protein expression, aiding research into cancer mechanisms.

Purpose of the Study:

  • To investigate the role of tetraspanins CD9 and CD151 in melanoma cell motility.
  • To evaluate the efficacy of RNA interference (iRNA) in silencing CD9 and CD151 expression in melanoma cells.
  • To determine the impact of CD9 and CD151 knockdown on melanoma cell migration.

Main Methods:

  • Utilized the A375 melanoma cell line.
  • Employed RNA interference (iRNA) to silence CD9 and CD151 expression.
  • Assessed cell motility using immunofluorescence, flow cytometry, cell transfection, and wound-healing assays.

Main Results:

  • A375 cells express both CD9 and CD151.
  • Successful inhibition of CD9 and CD151 expression was achieved using iRNA.
  • Knockdown of CD9 significantly reduced melanoma cell motility.

Conclusions:

  • RNA interference effectively silenced CD9 and CD151 in A375 melanoma cells.
  • CD9 inhibition markedly decreased cell migration, indicating its crucial role.
  • Tetraspanin knockdown presents a promising therapeutic strategy for melanoma treatment.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...